SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 27 filers reported holding SILENCE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $157,000 | – | 6,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,312,233 | $12,886,128 | 11.68% |
| M28 Capital Management LP | 363,800 | $3,572,516 | 4.10% |
| TCG Crossover Management, LLC | 2,104,875 | $20,669,873 | 3.04% |
| Lombard Odier Asset Management (Europe) Ltd | 3,443,912 | $33,819,216 | 1.73% |
| Lynx1 Capital Management LP | 235,787 | $2,315,428 | 1.53% |
| Artal Group S.A. | 2,500,000 | $24,550 | 1.05% |
| Lombard Odier Asset Management (USA) Corp | 4,057,932 | $33,740,000 | 0.76% |
| Deep Track Capital, LP | 1,951,580 | $19,164,516 | 0.74% |
| Frazier Life Sciences Management, L.P. | 881,173 | $8,661,931 | 0.58% |
| BVF INC/IL | 1,508,416 | $14,827,729 | 0.40% |